1001 related articles for article (PubMed ID: 16098456)
21. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
Murphy MJ
Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
[TBL] [Abstract][Full Text] [Related]
22. [Current status and prospectives of aromatase inhibitors in the treatment of advanced breast cancer].
Boccardo F
Minerva Ginecol; 1998 Mar; 50(3):51-63. PubMed ID: 9595916
[TBL] [Abstract][Full Text] [Related]
23. [Current status of adjuvant endocrine therapy for hormone responsive breast cancer].
Ikeda T; Jinno H; Masamura S; Matsui A; Tajima G; Hohjoh T; Tokura H; Mitsui Y; Asaga S; Muto T; Fujiwara K; Kitajima M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):902-8. PubMed ID: 11478138
[TBL] [Abstract][Full Text] [Related]
24. Emerging role of aromatase inhibitors in the adjuvant setting.
Goss PE
Am J Clin Oncol; 2003 Aug; 26(4):S27-33. PubMed ID: 12902874
[TBL] [Abstract][Full Text] [Related]
25. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Lee JH; Recht A
J Clin Oncol; 2003 Jun; 21(12):2260-7. PubMed ID: 12805324
[TBL] [Abstract][Full Text] [Related]
26. Hormonal approaches to breast cancer treatment and prevention: an overview.
Vogel CL
Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459
[TBL] [Abstract][Full Text] [Related]
27. Endocrine therapy of advanced disease: analysis and implications of the existing data.
Pritchard KI
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):460S-7S. PubMed ID: 12538501
[TBL] [Abstract][Full Text] [Related]
28. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
Vogel VG; Costantino JP; Wickerham DL; Cronin WM
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
[TBL] [Abstract][Full Text] [Related]
29. Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.
Aapro MS; Forbes JF
Breast Cancer Res Treat; 2003; 80 Suppl 1():S3-11; discussion S13-8. PubMed ID: 14535530
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
Kahlert S; von Koch F; Ditsch N; Untch M
Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):102-12. PubMed ID: 15073439
[TBL] [Abstract][Full Text] [Related]
31. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
Friedrichs K; Jänicke F
Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Crivellari D; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Lindtner J; Fey MF; Senn HJ; Coates AS; Collins J; Goldhirsch A;
J Clin Oncol; 2003 Dec; 21(24):4517-23. PubMed ID: 14673038
[TBL] [Abstract][Full Text] [Related]
33. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
Buzdar AU
Oncologist; 2003; 8(4):335-41. PubMed ID: 12897330
[TBL] [Abstract][Full Text] [Related]
34. Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003.
Buzdar AU
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):355S-61S. PubMed ID: 14734491
[TBL] [Abstract][Full Text] [Related]
35. [Aromatase inhibitors: therapeutic outlook].
Namer M
Bull Cancer; 2000 Dec; 87 Spec No():41-5. PubMed ID: 11250607
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of aromatase inhibitors in the treatment of advanced breast cancer.
Trunet PF; Vreeland F; Royce C; Chaudri HA; Cooper J; Bhatnagar AS
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):241-5. PubMed ID: 9365196
[TBL] [Abstract][Full Text] [Related]
37. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
Carlson RW; Henderson IC
Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant endocrine therapy for breast cancer: an overlooked option?
Wong ZW; Ellis MJ
Oncology (Williston Park); 2004 Apr; 18(4):411-20; discussion 421, 424, 429 passim. PubMed ID: 15134351
[TBL] [Abstract][Full Text] [Related]
39. The evolving role of aromatase inhibitors in breast cancer.
Mokbel K
Int J Clin Oncol; 2002 Oct; 7(5):279-83. PubMed ID: 12402060
[TBL] [Abstract][Full Text] [Related]
40. Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.
Buzdar A
Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S42-8. PubMed ID: 12756078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]